POLIANA DESARDEN: Open Payments
NPI 1114695418 · PLANT CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,141 in 113 payments from 19 companies in 2025. Trend: 2023 $1,925 · 2024 $2,235 · 2025 $2,141
Food & beverage: $2,141
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 24 | $432 |
| AstraZeneca Pharmaceuticals LP | 15 | $298 |
| Amgen Inc. | 18 | $259 |
| ABBVIE INC. | 13 | $203 |
| Astellas Pharma US Inc | 5 | $138 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $124 |
| GlaxoSmithKline, LLC. | 6 | $119 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $89 |
| Lilly USA, LLC | 4 | $88 |
| PFIZER INC. | 4 | $84 |
Products named: Ozempic, AIRSUPRA, OTEZLA, VRAYLAR, Veozah, Kerendia, JARDIANCE, CAPLYTA.
Industry payments across FL — which companies pay providers there.
